Cite
MLA Citation
Mario E. Lacouture et al.. “Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines.” Oncologist, vol. 26, 2021, pp. e316–e326. http://access.bl.uk/ark:/81055/vdc_100122360739.0x000032